author · SDG 3

Publications by Rajesh Kumar Gupta

Publications by Rajesh Kumar Gupta at Dr. D. Y. Patil Vidyapeeth, Pune, aligned with SDG 3: Good Health and Well-being. 9 publications.

← All publications in SDG 3

1. Disease microenvironment preconditioning: An evolving approach to improve therapeutic efficacy of human mesenchymal stromal cells
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · International Immunopharmacology (2025)
2. Overcoming the novel glycan-lectin checkpoints in tumor microenvironment for the success of the cross-presentation-based immunotherapy
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Biomaterials Science (2025)
3. Preparation of glycopeptide-modified pH-sensitive liposomes for promoting antigen cross-presentation and induction of antigen-specific cellular immunity
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Biomaterials Science (2024)
4. Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Vaccines (2022)
5. Sensing the interactions between carbohydrate-binding agents and <i>N</i>-linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Journal of Biomolecular Structure and Dynamics (2020)
6. Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Current Protein and Peptide Science (2020)
7. Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Seminars in Cancer Biology (2020)
8. Purification and characterization of pectins from Abelmoschus esculentus (okra pods) and Citrus limetta (citrus peels) and in silico binding study of pectin and pectic polysaccharides with galectin-1
   Physiology · Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Dr. D. Y. Patil Medical College, Hospital and Research Centre · DOAJ (DOAJ: Directory of Open Access Journals) (2020)
9. Engineering anti-cancer nanovaccine based on antigen cross-presentation
   Biotechnology · Dr. D.Y. Patil Vidyapeeth, Pune · Bioscience Reports (2019)